{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:06:14Z","timestamp":1792667174942,"version":"4.5.0"},"reference-count":176,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03408"],"award-info":[{"award-number":["19H03408"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Increasing evidence suggests that inflammatory responses are involved in the progression of brain injuries induced by a diverse range of insults, including ischemia, hemorrhage, trauma, epilepsy, and degenerative diseases. During the processes of inflammation, disruption of the blood\u2013brain barrier (BBB) may play a critical role in the enhancement of inflammatory responses and may initiate brain damage because the BBB constitutes an interface between the brain parenchyma and the bloodstream containing blood cells and plasma. The BBB has a distinct structure compared with those in peripheral tissues: it is composed of vascular endothelial cells with tight junctions, numerous pericytes surrounding endothelial cells, astrocytic endfeet, and a basement membrane structure. Under physiological conditions, the BBB should function as an important element in the neurovascular unit (NVU). High mobility group box-1 (HMGB1), a nonhistone nuclear protein, is ubiquitously expressed in almost all kinds of cells. HMGB1 plays important roles in the maintenance of chromatin structure, the regulation of transcription activity, and DNA repair in nuclei. On the other hand, HMGB1 is considered to be a representative damage-associated molecular pattern (DAMP) because it is translocated and released extracellularly from different types of brain cells, including neurons and glia, contributing to the pathophysiology of many diseases in the central nervous system (CNS). The regulation of HMGB1 release or the neutralization of extracellular HMGB1 produces beneficial effects on brain injuries induced by ischemia, hemorrhage, trauma, epilepsy, and Alzheimer\u2019s amyloidpathy in animal models and is associated with improvement of the neurological symptoms. In the present review, we focus on the dynamics of HMGB1 translocation in different disease conditions in the CNS and discuss the functional roles of extracellular HMGB1 in BBB disruption and brain inflammation. There might be common as well as distinct inflammatory processes for each CNS disease. This review will provide novel insights toward an improved understanding of a common pathophysiological process of CNS diseases, namely, BBB disruption mediated by HMGB1. It is proposed that HMGB1 might be an excellent target for the treatment of CNS diseases with BBB disruption.<\/jats:p>","DOI":"10.3390\/cells9122650","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T20:18:22Z","timestamp":1607631502000},"page":"2650","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["High Mobility Group Box-1 and Blood\u2013Brain Barrier Disruption"],"prefix":"10.3390","volume":"9","author":[{"given":"Masahiro","family":"Nishibori","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengli","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Ousaka","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Wake","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1007\/s12035-020-02023-z","article-title":"The Role of Neurovascular System in Neurodegenerative Diseases","volume":"57","author":"Ahmad","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain Barrier: From Physiology to Disease and Back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fimmu.2012.00132","article-title":"Post-ischemic inflammation in the brain","volume":"3","author":"Shichita","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and Dysfunction of the Blood-Brain Barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","article-title":"Pericytes: Developmental, physiological, and pathological perspectives, problems, and promises","volume":"21","author":"Armulik","year":"2011","journal-title":"Dev. Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","article-title":"Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients","volume":"16","author":"Achour","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/jnc.14446","article-title":"Identification and quantification of blood-brain barrier transporters in isolated rat brain microvessels","volume":"146","author":"Achour","year":"2018","journal-title":"J. Neurochem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.dmpk.2019.09.003","article-title":"Developmental changes in transporter and receptor protein expression levels at the rat blood-brain barrier based on quantitative targeted absolute proteomics","volume":"35","author":"Omori","year":"2020","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood-brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12975-016-0504-4","article-title":"Pericytes in Brain Injury and Repair After Ischemic Stroke","volume":"8","author":"Cai","year":"2017","journal-title":"Transl. Stroke Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: Key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1096\/fj.07-8770com","article-title":"Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats","volume":"21","author":"Liu","year":"2007","journal-title":"FASEB J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/STROKEAHA.110.598334","article-title":"Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats","volume":"42","author":"Zhang","year":"2011","journal-title":"Stroke A J. Cereb. Circ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"46243","DOI":"10.1038\/srep46243","article-title":"Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.23602","article-title":"Anti-high mobility group box-1 antibody therapy for traumatic brain injury","volume":"72","author":"Okuma","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2014.05.007","article-title":"Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction","volume":"85","author":"Okuma","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrneurol.2010.74","article-title":"Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury","volume":"6","author":"Shlosberg","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nbd.2018.06.022","article-title":"Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy","volume":"123","author":"Dadas","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41598-017-01325-y","article-title":"Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice","volume":"7","author":"Fu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1523\/JNEUROSCI.1751-04.2004","article-title":"Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex","volume":"24","author":"Seiffert","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"Araujo","year":"2007","journal-title":"Brain"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","article-title":"The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease","volume":"96","author":"Iadecola","year":"2017","journal-title":"Neuron"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jphs.2019.04.006","article-title":"Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases","volume":"140","author":"Nishibori","year":"2019","journal-title":"J. Pharmacol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nm.2749","article-title":"Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain","volume":"18","author":"Shichita","year":"2012","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/pr.117.014647","article-title":"Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions","volume":"70","author":"Erickson","year":"2018","journal-title":"Pharm. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbrc.2010.10.058","article-title":"Therapeutic effect of IL-12\/23 and their signaling pathway blockade on brain ischemia model","volume":"402","author":"Konoeda","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16625","DOI":"10.1016\/S0021-9258(18)49302-7","article-title":"Isolation and Some Characteristics of an Adhesive Factor of Brain That Enhances Neurite Outgrowth in Central Neurons","volume":"262","author":"Rauvala","year":"1987","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16722","DOI":"10.1016\/S0021-9258(18)55361-8","article-title":"30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane","volume":"266","author":"Merenmies","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19726","DOI":"10.1016\/S0021-9258(19)36575-5","article-title":"Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation","volume":"268","author":"Parkkinen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: Sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2020.00484","article-title":"Targeting Inflammation Driven by HMGB1","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s10020-020-00172-4","article-title":"Extracellular HMGB1: A therapeutic target in severe pulmonary inflammation including COVID-19?","volume":"26","author":"Andersson","year":"2020","journal-title":"Mol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.immuni.2018.08.016","article-title":"The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis","volume":"49","author":"Deng","year":"2018","journal-title":"Immunity"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"12126","DOI":"10.1016\/S0021-9258(18)63828-1","article-title":"Introduction and expression of the human insulin gene in adult rat liver","volume":"264","author":"Kaneda","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2015.05.028","article-title":"Brain pericytes are the most thrombin-sensitive matrix metalloproteinase-9-releasing cell type constituting the blood-brain barrier in vitro","volume":"599","author":"Machida","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1742-2094-8-106","article-title":"Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-alpha, releasing matrix metalloproteinase-9 and migrating in vitro","volume":"8","author":"Takata","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1523\/JNEUROSCI.2891-16.2016","article-title":"Pericytes as Inducers of Rapid, Matrix Metalloproteinase-9-Dependent Capillary Damage during Ischemia","volume":"37","author":"Underly","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.celrep.2017.12.016","article-title":"Dynamic Remodeling of Pericytes In Vivo Maintains Capillary Coverage in the Adult Mouse Brain","volume":"22","author":"Berthiaume","year":"2018","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00401-018-1893-0","article-title":"Targeting pericytes for therapeutic approaches to neurological disorders","volume":"136","author":"Cheng","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"E7622","DOI":"10.1073\/pnas.1710848114","article-title":"CD146 coordinates brain endothelial cell-pericyte communication for blood-brain barrier development","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","article-title":"SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers","volume":"19","author":"Morris","year":"2017","journal-title":"AAPS J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Abdul Razzak, R., Florence, G.J., and Gunn-Moore, F.J. (2019). Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20123108"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Gao, S.Z., Wake, H., Sakaguchi, M., Wang, D.L., Takahashi, Y., Teshigawara, K., Zhong, H., Mori, S., Liu, K.Y., and Takahashi, H. (2020). Histidine-Rich Glycoprotein Inhibits High-Mobility Group Box-1-Mediated Pathways in Vascular Endothelial Cells through CLEC-1A. iScience, 23.","DOI":"10.1016\/j.isci.2020.101180"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1523\/JNEUROSCI.3815-05.2006","article-title":"HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain","volume":"26","author":"Kim","year":"2006","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1471-4159.2007.04788.x","article-title":"High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo","volume":"103","author":"Faraco","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/jnr.21555","article-title":"Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain","volume":"86","author":"Kim","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.jcbfm.9600582","article-title":"Early release of HMGB-1 from neurons after the onset of brain ischemia","volume":"28","author":"Qiu","year":"2008","journal-title":"J. Cereb. Blood Flow Metab. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2018.09.007","article-title":"High-mobility group box-1 translocation and release after hypoxic ischemic brain injury in neonatal rats","volume":"311","author":"Chen","year":"2019","journal-title":"Exp. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuroscience.2012.10.023","article-title":"High-mobility group box 1 protein promotes neuroinflammation after intracerebral hemorrhage in rats","volume":"228","author":"Lei","year":"2013","journal-title":"Neuroscience"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.05.033","article-title":"Elevated Serum High-Mobility Group Box-1 Protein Level Is Associated with Poor Functional Outcome in Ischemic Stroke","volume":"26","author":"Tsukagawa","year":"2017","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Xiong, K.L., Lin, S., Zhong, Q., Lu, F.L., Liang, H., Li, J.C., Wang, J.Z., and Yang, Q.W. (2010). Elevation of high-mobility group protein box-1 in serum correlates with severity of acute intracerebral hemorrhage. Mediat. Inflamm., 2010.","DOI":"10.1155\/2010\/142458"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12028-009-9276-y","article-title":"High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage","volume":"11","author":"Nakahara","year":"2009","journal-title":"Neurocrit. Care"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.05.002","article-title":"HMGB1 Level in Cerebrospinal Fluid as a Marker of Treatment Outcome in Patients with Acute Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage","volume":"24","author":"Sokol","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.bbadis.2014.04.031","article-title":"Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome","volume":"1842","author":"Sapojnikova","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"105055","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105055","article-title":"Prognostic value of plasma HMGB1 in ischemic stroke patients with cerebral ischemia-reperfusion injury after intravenous thrombolysis","volume":"29","author":"Wang","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis. J. Natl. Stroke Assoc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2014.07.002","article-title":"Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway","volume":"1582","author":"Zhang","year":"2014","journal-title":"Brain Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fneur.2019.00889","article-title":"Small Vessels Are a Big Problem in Neurodegeneration and Neuroprotection","volume":"10","author":"Erdener","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/nm.2022","article-title":"Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery","volume":"15","author":"Yemisci","year":"2009","journal-title":"Nat. Med."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Richard, S.A., Sackey, M., Su, Z., and Xu, H. (2017). Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke. Biosci. Rep., 37.","DOI":"10.1042\/BSR20171104"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.expneurol.2015.11.003","article-title":"Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson\u2019s disease","volume":"275","author":"Sasaki","year":"2016","journal-title":"Exp. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbi.2018.06.012","article-title":"DNA binding protein HMGB1 secreted by activated microglia promotes the apoptosis of hippocampal neurons in diabetes complicated with OSA","volume":"73","author":"Shi","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2013.11.006","article-title":"Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain","volume":"558","author":"Shin","year":"2014","journal-title":"Neurosci. Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1093\/emboj\/cdg516","article-title":"Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion","volume":"22","author":"Bonaldi","year":"2003","journal-title":"EMBO J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2018.08.040","article-title":"Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk","volume":"141","author":"Sekiguchi","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.4049\/jimmunol.1400359","article-title":"PARP-1 Mediates LPS-Induced HMGB1 Release by Macrophages through Regulation of HMGB1 Acetylation","volume":"193","author":"Yang","year":"2014","journal-title":"J. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Wang, D., Liu, K., Fukuyasu, Y., Teshigawara, K., Fu, L., Wake, H., Ohtsuka, A., and Nishibori, M. (2020). HMGB1 Translocation in Neurons after Ischemic Insult: Subcellular Localization in Mitochondria and Peroxisomes. Cells, 9.","DOI":"10.3390\/cells9030643"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/jnc.13434","article-title":"Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloprotease-9 up-regulation in mice with painful peripheral neuropathy","volume":"136","author":"Zhang","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1179\/174313209X382395","article-title":"Peri-operative measures for treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage","volume":"31","author":"Alaraj","year":"2009","journal-title":"Neurol. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.STR.16.4.562","article-title":"Cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"16","author":"Kassell","year":"1985","journal-title":"Stroke A J. Cereb. Circ."},{"key":"ref_77","first-page":"509707","article-title":"Vasospasm in cerebral inflammation","volume":"2014","author":"Eisenhut","year":"2014","journal-title":"Int. J. Inflam."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/00004647-200107000-00013","article-title":"Hydroxyfasudil, an active metabolite of fasudil hydrochloride, relaxes the rabbit basilar artery by disinhibition of myosin light chain phosphatase","volume":"21","author":"Nakamura","year":"2001","journal-title":"J. Cereb. Blood Flow Metab. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nec.2009.10.008","article-title":"Inflammation and cerebral vasospasm after subarachnoid hemorrhage","volume":"21","author":"Pradilla","year":"2010","journal-title":"Neurosurg. Clin. N. Am."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Manoel, A.L.D., and Macdonald, R.L. (2018). Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.00292"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","article-title":"Delayed neurological deterioration after subarachnoid haemorrhage","volume":"10","author":"Macdonald","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3171\/2013.3.JNS121436","article-title":"Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: A meta-analysis of randomized controlled trials","volume":"119","author":"Shen","year":"2013","journal-title":"J. Neurosurg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bja\/aew095","article-title":"Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: A systematic review","volume":"117","author":"Veldeman","year":"2016","journal-title":"Br. J. Anaesth."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3171\/JNS-07\/07\/0128","article-title":"Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage","volume":"107","author":"Iseda","year":"2007","journal-title":"J. Neurosurg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.STR.32.1.225","article-title":"Inhibition of poly(ADP-ribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits","volume":"32","author":"Satoh","year":"2001","journal-title":"Stroke A J. Cereb. Circ."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/sj.jcbfm.9600456","article-title":"Potential contribution of nuclear factor-kappaB to cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits","volume":"27","author":"Zhou","year":"2007","journal-title":"J. Cereb. Blood Flow Metab. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"37755","DOI":"10.1038\/srep37755","article-title":"Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats","volume":"6","author":"Haruma","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/01616412.2017.1316903","article-title":"Glycyrrhizic acid exerts anti-inflammatory effect to improve cerebral vasospasm secondary to subarachnoid hemorrhage in a rat model","volume":"39","author":"Li","year":"2017","journal-title":"Neurol. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1161\/STROKEAHA.107.487769","article-title":"Prevention of the hypercontractile response to thrombin by proteinase-activated receptor-1 antagonist in subarachnoid hemorrhage","volume":"38","author":"Kai","year":"2007","journal-title":"Stroke A J. Cereb. Circ."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.bjp.0707435","article-title":"Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage","volume":"152","author":"Maeda","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_91","first-page":"161","article-title":"Expression of high-mobility group box-1 (HMGB1) in the basilar artery after experimental subarachnoid hemorrhage","volume":"27","author":"Zhao","year":"2016","journal-title":"J. Clin. Neurosci. J. Neurosurg. Soc. Australas."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.cca.2012.07.002","article-title":"Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury","volume":"413","author":"Wang","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1089\/neu.2011.2171","article-title":"Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury","volume":"29","author":"Au","year":"2012","journal-title":"J. Neurotrauma"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4569521","DOI":"10.1155\/2016\/4569521","article-title":"Inhibiting HMGB1 with Glycyrrhizic Acid Protects Brain Injury after DAI via Its Anti-Inflammatory Effect","volume":"2016","author":"Pang","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"807142","DOI":"10.1155\/2011\/807142","article-title":"Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4\/NF-kappaB pathway after traumatic brain injury in the rat","volume":"2011","author":"Su","year":"2011","journal-title":"Mediat. Inflamm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"112979","DOI":"10.1016\/j.expneurol.2019.112979","article-title":"Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences","volume":"320","author":"Webster","year":"2019","journal-title":"Exp. Neurol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neures.2018.03.004","article-title":"Therapeutic time window of anti-high mobility group box-1 antibody administration in mouse model of spinal cord injury","volume":"141","author":"Nakajo","year":"2019","journal-title":"Neurosci. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/stem.2802","article-title":"Prior Treatment with Anti-High Mobility Group Box-1 Antibody Boosts Human Neural Stem Cell Transplantation-Mediated Functional Recovery After Spinal Cord Injury","volume":"36","author":"Uezono","year":"2018","journal-title":"Stem Cells"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/neu.2018.5664","article-title":"Lack of Benefit on Brain Edema, Blood-Brain Barrier Permeability, or Cognitive Outcome in Global Inducible High Mobility Group Box 1 Knockout Mice Despite Tissue Sparing after Experimental Traumatic Brain Injury","volume":"36","author":"Aneja","year":"2019","journal-title":"J. Neurotrauma"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.23567","article-title":"Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage","volume":"72","author":"Librizzi","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eplepsyres.2009.03.005","article-title":"Blood-brain barrier breakdown-inducing astrocytic transformation: Novel targets for the prevention of epilepsy","volume":"85","author":"Friedman","year":"2009","journal-title":"Epilepsy Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2013.03.006","article-title":"Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures","volume":"58","author":"Iori","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_103","first-page":"737","article-title":"Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage","volume":"25","author":"Louboutin","year":"2011","journal-title":"FASEB J. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1167.2006.00817.x","article-title":"The blood-brain barrier and epilepsy","volume":"47","author":"Oby","year":"2006","journal-title":"Epilepsia"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"8672","DOI":"10.1523\/JNEUROSCI.4806-13.2014","article-title":"A novel, noninvasive, predictive epilepsy biomarker with clinical potential","volume":"34","author":"Choy","year":"2014","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Patterson, K.P., Brennan, G.P., Curran, M., Kinney-Lang, E., Dube, C., Rashid, F., Ly, C., Obenaus, A., and Baram, T.Z. (2015). Rapid, Coordinate Inflammatory Responses after Experimental Febrile Status Epilepticus: Implications for Epileptogenesis. eNeuro, 2.","DOI":"10.1523\/ENEURO.0034-15.2015"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2017.02.002","article-title":"Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy","volume":"64","author":"Zhao","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fncel.2016.00099","article-title":"Mitochondrial Translocation of High Mobility Group Box 1 Facilitates LIM Kinase 2-Mediated Programmed Necrotic Neuronal Death","volume":"10","author":"Hyun","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fncel.2018.00301","article-title":"Differential Roles of Mitochondrial Translocation of Active Caspase-3 and HMGB1 in Neuronal Death Induced by Status Epilepticus","volume":"12","author":"Kim","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jphp.13040","article-title":"Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus","volume":"71","author":"Li","year":"2019","journal-title":"J. Pharm. Pharm."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fncel.2019.00380","article-title":"Detrimental Effects of HMGB-1 Require Microglial-Astroglial Interaction: Implications for the Status Epilepticus -Induced Neuroinflammation","volume":"13","author":"Rosciszewski","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s13311-019-00815-3","article-title":"HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window","volume":"17","author":"Zhao","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fnins.2018.00628","article-title":"HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction","volume":"12","author":"Paudel","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbi.2017.10.008","article-title":"High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy","volume":"72","author":"Ravizza","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"106301","DOI":"10.1016\/j.eplepsyres.2020.106301","article-title":"Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures","volume":"162","author":"Nass","year":"2020","journal-title":"Epilepsy Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"173189","DOI":"10.1016\/j.ejphar.2020.173189","article-title":"HMGB1 promoted P-glycoprotein at the blood-brain barrier in MCAO rats via TLR4\/NF-kappaB signaling pathway","volume":"880","author":"Wang","year":"2020","journal-title":"Eur. J. Pharm."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3892\/mmr.2017.6772","article-title":"HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains via the RAGE\/NF-kappaB signaling pathway","volume":"16","author":"Xie","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","article-title":"Vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease\u2014A review of endothelium-mediated mechanisms and ensuing vicious circles","volume":"82","author":"Venneri","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Festoff, B.W., Sajja, R.K., van Dreden, P., and Cucullo, L. (2016). HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer\u2019s disease. J. Neuroinflamm., 13.","DOI":"10.1186\/s12974-016-0670-z"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer\u2019s disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/bpa.12685","article-title":"Extravascular fibrinogen in the white matter of Alzheimer\u2019s disease and normal aged brains: Implications for fibrinogen as a biomarker for Alzheimer\u2019s disease","volume":"29","author":"McAleese","year":"2019","journal-title":"Brain Pathol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2006.05.016","article-title":"Microvascular injury and blood-brain barrier leakage in Alzheimer\u2019s disease","volume":"28","author":"Zipser","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1523\/JNEUROSCI.6102-11.2012","article-title":"Abeta(1)(-)(4)(2)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca(2)(+)-calcineurin signaling","volume":"32","author":"Kook","year":"2012","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jnc.13122","article-title":"Abeta(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins","volume":"134","author":"Wan","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: A matter of blood-brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1523\/JNEUROSCI.0204-08.2008","article-title":"Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction","volume":"28","author":"Origlia","year":"2008","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e1288","DOI":"10.1038\/cddis.2014.248","article-title":"Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury","volume":"5","author":"Zhang","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Fujita, K., Motoki, K., Tagawa, K., Chen, X.G., Hama, H., Nakajima, K., Homma, H., Tamura, T., Watanabe, H., and Katsuno, M. (2016). HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer\u2019s disease. Sci. Rep., 6.","DOI":"10.1038\/srep31895"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2183\/pjab.93.022","article-title":"Ultra-Early Phase pathologies of Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"93","author":"Okazawa","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2016.02.018","article-title":"In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson\u2019s disease which can be attenuated by glycyrrhizin","volume":"91","author":"Santoro","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2018.03.031","article-title":"HMGB1 promotes the starvation-induced autophagic degradation of alpha-synuclein in SH-SY5Y cells Atg 5-dependently","volume":"202","author":"Guan","year":"2018","journal-title":"Life Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13000-016-0459-5","article-title":"Beclin1 and HMGB1 ameliorate the alpha-synuclein-mediated autophagy inhibition in PC12 cells","volume":"11","author":"Wang","year":"2016","journal-title":"Diagn. Pathol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1189\/jlb.1207844","article-title":"Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis","volume":"84","author":"Andersson","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaut.2013.02.005","article-title":"High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis","volume":"43","author":"Robinson","year":"2013","journal-title":"J. Autoimmun."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fimmu.2018.01518","article-title":"Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release","volume":"9","author":"Sun","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/cei.12036","article-title":"Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis","volume":"172","author":"Uzawa","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.neuroscience.2012.08.041","article-title":"Elevated Plasma High-Mobility Group Box 1 Protein Is a Potential Marker for Neuromyelitis Optica","volume":"226","author":"Wang","year":"2012","journal-title":"Neuroscience"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-clinpsy-050817-084811","article-title":"Risk Factors for Depression: An Autobiographical Review","volume":"14","author":"Hammen","year":"2018","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbi.2017.10.025","article-title":"Depression and sterile inflammation: Essential role of danger associated molecular patterns","volume":"72","author":"Franklin","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbi.2015.12.012","article-title":"Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior","volume":"53","author":"Cheng","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbi.2016.09.017","article-title":"Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1","volume":"59","author":"Lian","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biopsych.2017.06.034","article-title":"Persistent Increase in Microglial RAGE Contributes to Chronic Stress-Induced Priming of Depressive-like Behavior","volume":"83","author":"Franklin","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pnpbp.2019.02.005","article-title":"High-mobility group box 1-mediated microglial activation induces anxiodepressive-like behaviors in mice with neuropathic pain","volume":"92","author":"Tomimura","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ebiom.2016.06.003","article-title":"Histidine-Rich Glycoprotein Prevents Septic Lethality through Regulation of Immunothrombosis and Inflammation","volume":"9","author":"Wake","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/1747493018806196","article-title":"Frequency of post-stroke pneumonia: Systematic review and meta-analysis of observational studies","volume":"14","author":"Badve","year":"2019","journal-title":"Int. J. Stroke"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Ge, Y.Q., Wang, Q.H., Wang, L., Wu, H.H., Peng, C., Wang, J.J., Xu, Y., Xiong, G., Zhang, Y.Y., and Yi, Y.P. (2019). Predicting post-stroke pneumonia using deep neural network approaches. Int. J. Med Inform., 132.","DOI":"10.1016\/j.ijmedinf.2019.103986"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/nm.4194","article-title":"Translocation and dissemination of commensal bacteria in post-stroke infection","volume":"22","author":"Stanley","year":"2016","journal-title":"Nat. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: Roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.intimp.2018.01.002","article-title":"Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4\/MyD88 pathway","volume":"56","author":"Cheng","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41419-018-0438-8","article-title":"Alarmin HMGB1 induces systemic and brain inflammatory exacerbation in post-stroke infection rat model","volume":"9","author":"Kim","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.24909","article-title":"The immune response of the human brain to abdominal surgery","volume":"81","author":"Forsberg","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22664","article-title":"Resolving postoperative neuroinflammation and cognitive decline","volume":"70","author":"Terrando","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jmv.25076","article-title":"Anti-high mobility group box-1 monoclonal antibody treatment of brain edema induced by influenza infection and lipopolysaccharide","volume":"90","author":"Nosaka","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The blood-brain barrier in systemic inflammation","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13054-020-03200-1","article-title":"Delirium and encephalopathy in severe COVID-19: A cohort analysis of ICU patients","volume":"24","author":"Helms","year":"2020","journal-title":"Crit. Care"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41423-020-0492-x","article-title":"Elevated serum levels of S100A8\/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients","volume":"17","author":"Chen","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e978720","DOI":"10.4161\/21688370.2014.978720","article-title":"Blood cells and endothelial barrier function","volume":"3","author":"Rodrigues","year":"2015","journal-title":"Tissue Barriers"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/brain\/awt064","article-title":"High mobility group box 1 prolongs inflammation and worsens disease in pneumococcal meningitis","volume":"136","author":"Hohne","year":"2013","journal-title":"Brain"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1159\/000489659","article-title":"HMGB1 a-Box Reverses Brain Edema and Deterioration of Neurological Function in a Traumatic Brain Injury Mouse Model","volume":"46","author":"Yang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/mt.2011.291","article-title":"Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain","volume":"20","author":"Kim","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neulet.2012.07.040","article-title":"Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain","volume":"525","author":"Kim","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1161\/01.STR.0000181779.83472.35","article-title":"Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window","volume":"36","author":"Yu","year":"2005","journal-title":"Stroke A J. Cereb. Circ."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/ALN.0b013e3181a160d6","article-title":"Ethyl Pyruvate Attenuates Spinal Cord Ischemic Injury with a Wide Therapeutic Window through Inhibiting High-mobility Group Box 1 Release in Rabbits","volume":"110","author":"Wang","year":"2009","journal-title":"Anesthesiology"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nbd.2011.12.056","article-title":"Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion","volume":"46","author":"Kim","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/00207454.2013.796551","article-title":"Glycyrrhizin protects spinal cord and reduces inflammation in spinal cord ischemia-reperfusion injury","volume":"123","author":"Ni","year":"2013","journal-title":"Int. J. Neurosci."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/aps.2011.151","article-title":"Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1","volume":"33","author":"Gong","year":"2012","journal-title":"Acta Pharm. Sin."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.neuropharm.2011.06.026","article-title":"HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats","volume":"61","author":"Ohnishi","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2009.12.046","article-title":"Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia","volume":"1321","author":"Wang","year":"2010","journal-title":"Brain Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41401-018-0160-1","article-title":"Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-kappaB nuclear translocation","volume":"39","author":"Zhu","year":"2018","journal-title":"Acta Pharm. Sin."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Xie, W., Zhu, T., Dong, X., Nan, F., Meng, X., Zhou, P., Sun, G., and Sun, X. (2019). HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-kappaB signaling pathways. Biomolecules, 9.","DOI":"10.3390\/biom9100512"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fneur.2018.00253","article-title":"Ursolic Acid Ameliorates Inflammation in Cerebral Ischemia and Reperfusion Injury Possibly via High Mobility Group Box 1\/Toll-Like Receptor 4\/NFkappaB Pathway","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12974-017-0917-3","article-title":"Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1\/TLR4\/NF-kappaB pathway following experimental traumatic brain injury","volume":"14","author":"Chen","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jns.2016.01.047","article-title":"Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice","volume":"362","author":"Nakamura","year":"2016","journal-title":"J. Neurol. Sci."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/12\/2650\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:43:02Z","timestamp":1760179382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/12\/2650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":176,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["cells9122650"],"URL":"https:\/\/doi.org\/10.3390\/cells9122650","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,10]]}}}